CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: CDK4/6 inhibitor
Sponsor: RenJi Hospital